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ABSTRACT 
The magnetic separation of pathogenic compounds from body fluids is an appealing therapeutic con-
cept. Recently, removal of a diverse array of pathogens has been demonstrated using extracorporeal 
dialysis-type devices. The contact time between the fluid and the magnetic beads in such devices is 
limited to a few minutes. This poses challenges, particularly if large compounds, such as bacteria or 
cells need to be removed. Here, we report on the feasibility to remove cells from body fluids in a con-
tinuous dialysis type of setting. We assessed tumor cell removal efficiencies from physiological fluids 
with or without white blood cells using a range of different magnetic bead sizes (50 nm – 4000 nm), 
concentrations and contact times. We show that tumor cells can be quantitatively removed from body 
fluids within acceptable times (1-2 minutes) and bead concentrations (0.2 mg per mL). We further pre-
sent a mathematical model to describe the minimal bead number concentration needed to remove a 
certain number of cells, in presence of competing non-specific uptake. The present study paves the 
way for investigational studies to assess the therapeutic potential of cell removal by magnetic blood 
purification in a dialysis-like setting.   
Page 3 of 24 
 
INTRODUCTION 
Magnetic separation offers a direct way for the removal of disease-causing factors from body fluids. 
Magnetic beads functionalized by a capturing moiety are employed to selectively bind to target com-
pounds and are then subsequently removed by magnetic separation.1-3 A variety of beads, mostly based 
on iron oxide, iron and iron carbide, have successfully been applied to capture target compounds. Re-
moval of a wide variety of different substances, including metal ions,4-5 small molecule drugs6-7 and 
proteins6 has been demonstrated in various in vitro and in vivo models. Recently, the concept has been 
extended to remove bacteria from body fluids in diagnostic,8 therapeutic9 and theranostic10 settings. A 
similar concept based on micron-sized magnetic beads has been employed for magnetic cell isolation 
in cell culture and diagnostics for decades already.11-13 While micron-sized beads work well for diag-
nostic applications, Xu and colleagues have highlighted significant drawbacks of microparticles, such 
as low surface area (and binding capacity) and slow binding.14 In the same report, they also have 
demonstrated promising separation efficiencies of tumor cells using 30 nm iron oxide beads in a batch 
type setting. The removal of tumor cells from body fluid holds some promise15 and various studies 
have been conducted on the isolation of circulating tumor cells (CTCs).1-3, 16-20 For example, McDon-
ald and colleagues have demonstrated in an early study that ovarian cancer progression in mice is 10-
fold lower when migratory tumor cells are removed by magnetic filtration from intraperitoneal 
fluids.21 Most of the reported results in the literature aim at the diagnosis1, 16-17, 20 and monitoring of 
cancer via isolation of CTCs from the blood stream of patients by microfluidic techniques.1, 3, 16-18, 20 
However, rapid therapeutic removal of cells by magnetic separation in a continuous process has not 
yet been investigated systematically, and intrinsic process limitations remain unclear.  
In a continuous extracorporeal process, similar to a dialysis setting, the contact time between 
the beads and the fluid containing the target cells is limited to a few minutes.22 While for efficient 
binding, long contact times would be beneficial, the receptor binding process is in competition with 
the uptake of particles into phagocytic cells. Additionally, long contact times compromise the overall 
process throughput. The effective removal of tumor cells relies on high particle-tumor cells collision 
frequencies and specific binding of magnetic clusters to tumor cells in presence of proteins and other 
cells, such as white blood cells. Here, we investigated the technical feasibility and limitations for the 
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therapeutic removal of cells from body fluids using a magnetic blood purification process in batch and 
continuous mode. We assessed the influence of bead size and concentration, and bead – body fluid 
contact times on tumor cell separation efficiency in presence of white blood cells, employing a combi-
nation of experimental and theoretical methods. 
 
MATERIALS AND METHODS 
Magnetic beads and antibodies. Protein A/G coated Bio-Adembeads from Ademtech (REF: 04631, 
Lot:15G022 − 1 and Lot:15L012 – 1) were used. For size and time dependence experiments, beads 
from Creative Diagnostic Absolute Mag™ were used in addition to the Adembeads. For all bead func-
tionalisations, the EpCAM antibody from Abcam (ab187372 [VU-1D9]) was used. EpCAM-FITC 
(ab112067 [VU-1D9]) was used for analysis of the EpCAM epitope on CaCo-2 cells. Transmission 
electron micrographs of beads were collected using a JEOL 100 Plus TEM. Hydrodynamic sizes of the 
particles were measured using a Dynamic Light Scattering (DLS) instrument (ZetaSizer, 90° configu-
ration).  
Bead functionalization. Bio-Adembeads were functionalized according to the manufacturer’s 
protocol for IgG cross-linking. The incubation time was increased to 1 hour. Bead pelleting was done 
in a 500 μL Eppendorf tube with a cubic Neodymium magnet, 4.6×3×1 cm, acquired from supermag-
nete.ch. Creative Diagnostics beads with a bead concentration of 10 mg per mL were functionalized by 
adding e.g. 1 μg of antibody to 10 μL of beads. The solution was then incubated for 1 hour at 1000 
rpm on the Heidolph Titramax 101 shaker. Subsequently, the tube was placed on the magnet until a 
bead pellet formed. The supernatant was discarded and the pellet was re-suspended in PBS. The wash-
ing was repeated twice. 
Cell lines. For all separation experiments the Caco-2 cell line (ACC169), acquired from 
Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH was used. Undifferentiated Caco-
2 cells were cultured in cell culture medium (Minimum Essential Medium Eagle (MEM), Sigma-
Aldrich, REF: M2279) containing 10% Fetal Calf Serum (FCS, Sigma-Aldrich, REF: F9665), 1% 
Non-Essential Amino Acids (Sigma-Aldrich, REF: M7145), 1% Penicillin-Streptomycin-Neomycin 
(Sigma-Aldrich, REF: P4083) and 1% L-Glutamine (Sigma-Aldrich, Ref. G7513). Cells were main-
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tained at 37°C and 5% CO2 in humidified atmosphere and routinely sub-cultured twice a week at 70-
80% confluence by treatment with 0.5% trypsin-EDTA (Sigma-Aldrich, REF: T3924). THP-1 cells 
(TIB-202) were acquired from American Type Culture Collection. THP-1 monocytic cells were cul-
tured in suspension in RPMI-1640 medium (Sigma-Aldrich, REF: R0883) supplemented with 10% 
FCS, 1% Penicillin-Streptomycin-Neomycin and 1% L-Glutamine and routinely sub-cultured once a 
week. 
AnnexinV/PI assay. In order to exclude acute cytotoxicity of the nanoparticles, apoptosis and 
necrosis induced were assessed. For detection of apoptotic and necrotic cells the FITC Annexin V 
Apoptosis Detection Kit I (Ref. 556547, BD Biosciences) was used. Caco-2 cells were seeded in 24 
well plates (50.000 cells/well or 2680 cells/cm2) and grown to 50-60% confluency before adding stim-
uli or nanoparticles. Cells were incubated in duplicates for 24 h with EpCAM- functionalized magnet-
ic beads in a concentration of 0.4 mg per mL (0.11 mg/cm2) and 0.04 mg per mL (0.01 mg/cm2). For 
short incubation, mimicking the therapeutic time scale, magnetic beads were spiked directly into the 
cell suspension during the staining procedure. Silica nanoparticles (Aerosil®200, Evonik) in the same 
concentrations served as a positive control for nanoparticle toxicity. Cadmium sulfate (100 μM) was 
added for 3 hrs to untreated cells as a control for necrosis while staurosporine (10 μM) was added for 4 
hrs as a control for the induction of apoptosis. After incubation with stimuli cells were harvested by 
treatment with Trypsin/EDTA and stained according to the manufacturer’s instructions. Cells were as-
sessed with the Gallios flow cytometer (10.000 events gated in forward/side scatter or 2 min max. ac-
quisition time) and the fluorescence signals of PI and AnnexinV-FITC were detected in FL4 or FL1 
respectively.  
Blood. Blood was donated in-house by healthy volunteers (n=5). Every donor signed a written 
consent approved by the ethical commission of St. Gallen (EKSG 12/111). After having obtained writ-
ten informed consent, 2-5 mL of citrated blood were withdrawn using a 20G needle. All donations 
were collected in a Vacutainer buffered with sodium citrate at 0.109 M (Belliver Industrial Estate, 
Plymouth, UK, Lot: 40340010). Only volunteers who have not taken any drugs known to affect plate-
let function for two weeks prior to donation were included. 
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Cell staining. Specific cell staining was performed to allow discrimination between the dif-
frent cell types after separation experiments in flow cytometry. The THP-1 cells were stained using 
Hoechst 33342, dissolved in PBS at a concentration of 0.5 μg per mL, incubated for 20 minutes at 
4°C. Caco-2 cells were stained with CellTracker Green CMFDA (Thermo Fisher Scientific, REF: 
C2925), dissolved in pre-warmed cell culture medium at a concentration of 60 μM, and incubated for 
15 minutes at 37°C. After incubation the cells were centrifuged at 200 ×g for 5 minutes and re-
suspended in prewarmed MEM cell culture medium.  
Cell separation experiments. Separation experiments were done in pre-warmed MEM with 
10% Fetal Calf Serum, 1% Non-Essential Amino Acids, 1% Penicillin-Streptomycin-Neomycin and 
1% L-Glutamine. Beads were functionalized according to the above described procedure. Cells were 
re-suspended in culture medium at a concentration of 100’000 cells per mL. For experiments with hu-
man leukocytes, blood was collected and part of the blood was incubated with VersaLyse buffer to 
lyse the red blood cells. Leukocytes were counted and used immediately or, when fixed leukocytes 
were required, the pellet was fixed in 4% PFA. The leukocytes were re-suspended in cell culture me-
dium, which contained 100’000 stained Caco-2 cells per mL. Then, 25μL of cell culture medium or 
25μL of beads were added to the samples and incubated at 37°C on a linear shaker. Magnetic separa-
tion was achieved by holding a cubic neodymium magnet next to the 1.5 mL Eppendorf for 1 minute. 
The entire supernatant was then aspirated. The pellet was re-suspended in cell culture medium. This 
allowed to analyze the total number of cells, on the one hand the separated residual cells and on the 
other the unseparated supernatant. Counting beads (CountBright™Absolute Counting Beads from Mo-
lecular Probes™) were then added and samples were analyzed in a flow cytometer. 
Flow cytometric analysis. A Beckmann & Coulter Gallios TM Flow Cytometer was used in 
combination with Kaluza Analysis Software. Samples that contained CellTracker Green stained cells 
were excited at 488nm and measured with a 525/540nm bandpass. Samples containing Hoechst 33342 
stained cells were excited at 405nm and measured with a 540/550nm bandpass. Counting beads were 
excited at 635nm and measured at 755nm. All samples were measured in Micronic 1.4mL tubes.  
To ensure comparable cell counts in every sample, data acquisition was stopped after 5,000 counting 
beads gated in fluorescence channel 7 (FL7).  Cells were gated according to their specific fluorescent 
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label in complex mixtures or depending on their forward and side scatter signal when only one cell 
type was involved. 
TEM sample preparation and imaging.  For electron microscopy, cells (White blood cells 
(WBC) and tumor cells (TC), incubated with particles for 10 minutes and 5 hours) were gently washed 
with pre-warmed PBS and fixed with 4% methanol-free paraformaldehyde (PFA) overnight in the 
fridge. Pellets were then washed with ddH2O (3x) and cacodylate buffer (0.1M) (2x) and stained with 
2% osmium tetroxide and 1.5% potassium ferricyanide for 1 hour. Pellets were washed with ddH2O 
and then gradually dehydrated using an ethanol gradient (40%, 50%, 60 %, 70%, 80%, 90%, 95%, 
100% (3x)). Cell pellets were then embedded in epoxy resin (EPON 812), according to procedures de-
scribed in the manufacturer’s protocol. Resin blocks were cured in the oven for 72 hours, trimmed 
with a razor blade and then sectioned in 100nm sections using an ultramicrotome. The thin sections 
were imaged in a JEOL 100 Plus TEM at 80 keV.  
Continuous experiment. A blood purification device was assembled at a scale of 1:10 of a pre-
viously constructed magnetic blood purification device.22 Two pumps (Ismatech Pump ISM 833C 
Type 335193) were used. Flow rates were set to 1.5mL per min for the main tube and beads were add-
ed at a 1:10 dilution. Functionalized beads were pumped in a PharMed®BPT orange/yellow tube into 
the main silicon TR60 2/4MM tube to reach a final bead concentration of 0.4 mg per mL. The silicon 
tube was replaced for each new sample. For experiments including a mixer, a pearl chain mixer (Fluid-
ic 658 from Microfluidic chipshop) was connected to the tubing. The volume of the entire device was 
5 mL. The volume between mixer and magnets was 3 mL, resulting in a contact time of 2 minutes. 
The beads were separated from the fluid flow by using two neodymium magnets, assembled using an 
in-house 3D-printed scaffold. Final cell concentrations were analyzed in flow cytometry by mixing 
300 μL of the cell suspension after separation with 25 μL of the counting beads. Acquisition was 
stopped after 5,000 counting beads and the residual cell number was determined for every sample.  
Mathematical Model. To quantify the time required for magnetic particles to bind to cells, and 
consequently gaining information about the time evolution of the fraction of cells with a given number 
magnetic particles bound to their surface, a mathematical model based on population balance equa-
tions has been used. This model, which is similar to the one used in our previous work,10 relies on the 
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solution of mass balances for the overall concentration of free magnetic particles, as well as for the 
concentration of cells carrying an arbitrary number i of magnetic particles bound to them. Let us call N 
the number concentration of unbound magnetic particles, and Ci the concentration of cells with i parti-
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M is the maximum number of particles that can be attached on a cell. Equation (1) states that the ad-
sorption of particles onto cells is described as a bimolecular event, proportional to the concentration of 
free particles and to the concentration of cells onto which particles are going to attach. The “rate con-
stant Ki”, corresponding to the rate of particle attaching on a cell with having already i particles bound 
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In Equation (2), RC is the radius of the cell, RMP the radius of the magnetic particles, T the absolute 
temperature, kB the Boltzmann constant and  the viscosity of the medium in which particles and cells 
move. The last term in the equation is the correction accounting for the fact that a cell with i particles 
bound to it has only a portion of its surface available for further particle attachment. When M particles 
are attached, no more particles can be attached, since the model does not foresee the possibility of 
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where CT is the total number of cells, which is equal to the initial number of cells with zero particles 
adsorbed on them. 
The second is the conservation of particles: 
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N0 is the initial and total number concentration of magnetic particles. 
It is possible to find a solution in closed form of Equations (1)-(5), as shown in the supporting infor-
mation. The closed form solution makes the calculations of all relevant quantities (such as the time 
evolution of the average number of particles bound to a cell) very easy.  
The model can be further extended to the case of unspecific binding. In this case, it is assumed that 
there are two populations of cells: those to which magnetic particles are supposed to bind, and the sec-
ond population, to which particles bind unspecifically, and with a considerably lower rate. Equations 
(3) still holds for the cells to which magnetic particles are supposed to bind. A similar set of Equations 
can be written in the case of cells with unspecific binding. Overall, the balance equations for the two 
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Where the symbols with subscript 1 and 2 refer to cells belonging to population 1 (specific) and 2 (un-
specific), respectively. The corresponding balance for the particles becomes: 
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M1 and M2 are the maximum number of particles that can bind to the two populations of cells. If the 
size of the two cells are identical, then M1 = M2. The only difference between the two rate constants is 
the presence of the W factor in the denominator of the second Equation (8). This factor, assumed to be 
W>>1, corrects for unspecific binding, which is assumed to be much slower than the specific binding. 
1/W represent the probability that a collision between a magnetic particle and a cell leads to an unspe-
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The solution of Equations (6)-(9) has been done partially analytically, partially numerically, as de-
scribed in the supporting information. 
 
RESULTS & DISCUSSION 
In order to investigate the receptor mediated specific binding of magnetic particles to cells and the ef-
ficiency of the magnetic separation process, EpCAM-positive tumor cells were chosen as a model cell 
line. EpCAM is a surface marker that is widely expressed by different tumor cells and has been used 
to separate tumor cells in diagnostic settings for many years already.17, 23 EpCAM antibody functional-
ized beads were assembled using Protein A (or Protein A/G hybrid) coated magnetic clusters with 
cluster diameters of 50 nm, 200 nm, 300 nm, 1 μm and 4 μm (according to the manufacturer) (Figure 
1a). Transmission electron micrographs of the 300 nm clusters show a uniform size and shape of the 
particles (Figure 1b). Dynamic light scattering (DLS) measurements show relatively narrow size dis-
tributions and average hydrodynamic sizes of 106(±0.7)nm, 264(±5)nm, 367(±1)nm, 432(±5)nm and 
3209 (±460)nm in water (Figure 1b). Hydrodynamic sizes in cell culture medium were comparable to 
the ones in water (see Supporting Information, Figure S1). These DLS sizes differentiate considerably 
from the expected size provided by the supplier for 1 μm and 4 μm particles. However, this may be 
explained by anisotropic particle shapes and inaccuracies in the estimate of the refractive index. 
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An EpCAM-positive and an EpCAM-negative cell line were selected for initial bead-cell in-
teraction studies. The EpCAM positivity of CaCo-2 cells and the low EpCAM expression on THP-1 
cells was confirmed by flow cytometry (Figure 2a,b). Then, 300 nm beads with and without EpCAM-
antibody attached were added to a suspension of Caco-2 cells (100’000 cells per mL) at a concentra-
tion of 0.4 mg per mL. The compatibility of the beads for at least the duration of a typical experiment 
and up to 24 hrs was demonstrated in a membrane integrity assay (Figure 2c). No significant effect on 
cell viability was observed and viability remained ≥ 90% for at least 24 hrs of incubation time. The 
non-specific interaction of protein A/G coated beads (without EpCAM-antibody) with Caco-2 cells 
was investigated (Figure 2d). Less than 5% of tumor cells were separated when beads without Ep-
CAM antibody were used. For EpCAM functionalized beads, separation efficiencies of >95% were 
reached using bead concentrations of 0.4 mg per mL and contact times of 10 minutes. These results 
show that there is very little non-specific interactions between cells and beads without antibody for in-
cubation times up to 10 minutes. Additionally, an analogous experiment with (EpCAM-negative) 
THP-1 cells shows that < 10% of THP-1 cells are removed by the EpCAM-antibody functionalized 
magnetic beads. To differentiate between the competitive receptor binding and endocytosis processes, 
separation efficiencies of fixed and unfixed tumor cells were compared. When PFA-fixed Caco-2 cells 
were used, separation efficiencies were slightly reduced and reached 60% for EpCAM-antibody func-
tionalized beads. Less than 1% of PFA-fixed cells were removed when beads without antibody were 
employed. 
Then, separation efficiencies of EpCAM-positive Caco-2 cells by EpCAM-antibody-
functionalized beads were assessed in presence of EpCAM-negative cells. First, a human monocyte 
cell line (THP-1) with comparatively low phagocytic activity was used as a model system. Binding of 
EpCAM-coated magnetic beads to EpCAM-negative THP-1 cells was found to be < 10% and separa-
tion efficiencies of Caco-2 cells in presence of THP-1 cells were >95%.  
To assess the influence of magnetic bead size on tumor cell binding and uptake into phagocyt-
ic cells, different bead sizes (50 nm, 200 nm, 300 nm, 1 μm and 4 μm) were compared at the same 
mass concentration in presence and absence of EpCAM-negative white blood cells (Figure 3a). Since 
undifferentiated THP-1 cells have a relatively low phagocytic activity native white blood cells isolated 
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from fresh human whole blood were employed to mimic conditions in human blood more realistically. 
At a concentration of 0.4 mg per mL, it becomes apparent that beads with sizes between 200 nm and 1 
μm are most efficient. This is in agreement with a study on bacteria removal from Kang et al.24 The 50 
nm beads are incompletely separated from the suspension by magnetic separation due to their weaker 
magnetic moment. Also, smaller beads are readily taken up by both WBC and TC, which possibly ex-
plains the slightly reduced separation efficacy in presence of WBC for 50 nm and 200 nm. On the oth-
er hand the number of 4 μm beads is too low to reach complete separation. This is in agreement with 
findings from Xu and colleagues, who report slow and inefficient binding of tumor cells by 3-5 μm 
beads.14  
Next, the influence of bead concentration was investigated using 300 nm beads (Figure 3b). 
Experiments show that beads are in excess and that bead concentration of down to 0.2 mg per mL lead 
to separation efficiencies of  >98%. However, in presence of white blood cells, with increasing incuba-
tion time, the minimum number of required beads to achieve quantitative separation is significantly 
higher, indicative of a competitive process of bead phagocytosis and binding of beads to tumor cells.  
The influence of contact time between the beads and the cells has shown little effect of the 
contact time on TC separation efficiencies for bead concentration of > 0.2 mg per mL (Figure 3c). 
However, a striking decrease in WBC, and particularly neutrophil counts is observed with increasing 
contact times (Figure 3d). After 10 minutes of contact time, the neutrophil count drops by 50% of the 
initial count (1 million per mL). Transmission electron micrographs confirm uptake of magnetic nano-
particles, with a preferential uptake of smaller particle (i.e. 300nm) compared to 4 μm particles (Fig-
ure 4a,b). Occasionally, also 4 μm particles are found inside of the cells (Figure 4b). These findings 
indicate that blood – bead contact times should be limited to a few minutes in order to avoid uptake of 
magnetic particles into white blood cells.  
Finally, we demonstrate efficacious removal of EpCAM-positive cells in a continuous process. 
We assembled a dialysis like system in analogy to the ones reported in previous studies.9, 22, 25 The 
volume of the device was 5 mL and fluid was pumped at a flow rate of 1.5 mL per min. Beads were 
added to the fluid stream at a final bead concentration of 0.4 mg per mL. In the continuous process, 
single pass tumor separation efficiency was found to be reduced (78.8%) compared to the batch setting 
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(>95%). In order to improve contact between beads and fluid, a microfluidic pearl chain mixer was in-
troduced (Figure 5a,b). Using the mixer, separation efficiency was increased from 78.8% to >92%, 
even in presence of physiological numbers of WBC (Figure 5c). The mixing of the beads with the 
cells is indeed a critical factor affecting separation performance. 
Notably, we have used comparatively high number concentrations of tumor cells. The reason 
for that is mostly of technical nature, since such high concentrations allow reliable cell counting by 
flow cytometry. The target cell concentration in certain clinical scenarios may be much lower, espe-
cially for circulating tumour cells where concentrations of ≤ 10 cells per mL are reported,23, 26 and this 
may affect separation performance. In order to address how target cell concentration will affect the 
removal efficiency, we calculated the estimated binding times based on a mathematical model. We 
used an estimated target cell size of 10 μm×10 μm×10 μm and a bead concentration of 5 × 109 beads 
per mL. The number of target cells was varied from 10 cells per mL to 100’000 cells per mL. The 
modelling results show that beads are added in such great excess that the cell concentration only mar-
ginally affects the removal efficiency (Figure 6a,b). The number of beads per cell increases irrespec-
tive of the cell number in that case (Figure 6c,d). In particular, Figure 6d shows the time evolution of 
cells with at least 10 magnetic beads. It is estimated that this is the requirement necessary to achieve 
good separation.24 One can see how in a couple of minutes all the cells contain at least 10 beads. Be-
cause particles are much smaller than cells in that case, the relative movements of particles are much 
faster, and cells can almost be considered as stationary phase.27 The rate-determining step in the bind-
ing process is the movement and the binding of nanoparticles to the cell surface, and the cell concen-
tration thus has very little effect on the separation efficiency. However, non-specific uptake may of 
course significantly affect the separation performance. We therefore adapted the model to take into ac-
count non-specific uptake. To do so, we assumed that particles can also attach to non-target cells, at a 
rate which is  times smaller than the rate of binding to target cells. We have performed a sensitivity 
analysis varying several parameters of the model, in order to assess the effect of unspecific binding on 
the outcome of the separation. The results of such analyses are shown in Figures S2-S3. The results 
are presented in terms of average number of cells bearing at least 10 particles as a function of the  
value, for two extremely different ratios of concentrations of specific versus unspecific cells, C1/C2. 
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Figure S2 shows four cases, corresponding to four different magnetic particles concentrations. One 
can observe that, for sufficiently low values of the parameter , the separation between specific and 
unspecific cells is almost complete. Not surprisingly, at  values sufficiently close to 1, the separation 
becomes progressively poorer, until specificity is completely lost. As the particle concentration de-
creases, it appears that the number of cells with at least 10 particles that are present after 10 minutes 
decreases considerably. As rule of thumb, in order to achieve an analogous performance, a decrease in 
particles concentration by about an order of magnitude can be compensated by an increase in contact 
time by one order of magnitude, as Figure S3 shows. In fact the fraction of cells with specific binding 
shown in Figures S2c and S3a are quite similar. In the former case, a concentration of particles of 
5·107 per mL has been used for 10 minutes, while in the letter case a particle concentration of 5·106 
per mL for a time of 100 minutes has been used. Clearly the fact that the final results are not identical 
is due to the non-identical consumption of particles, which becomes a problem when their concentra-
tion becomes sufficiently small, as Figure S2b shows, where a particle concentration of 5·106 per mL 
for a time of 1000 minutes has been used. The almost complete consumption of particles in the latter 
case can be seen in Figure S3d. Taken together, this model enables estimation of the minimal particle 




The present article demonstrates the conceptual feasibility of cell removal from body fluids in a con-
tinuous extracorporeal dialysis-type of setting. The contact between magnetic beads and target sub-
stances is critical, and can be enhanced by introducing a pearl chain mixer. Contact times higher than 2 
minutes should be avoided in order to prevent non-specific uptake into blood cells. Also, particle sur-
face chemistry may be further optimized in order to improve specific cell binding and limit non-
specific interactions. The current setting could be easily scaled up to increase the throughput to 50-150 
mL per min, similar to the ones of currently used blood purification devices. This study paves the way 
to investigate the therapeutic benefit of magnetic cell removal in conditions such as metastatic cancer 
or leukaemia, where circulating tumor cells could be removed, or in autoimmune diseases. 
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SUPPORTING INFORMATION. 
Figure S1. Hydrodynamic size of magnetic beads in water and cell culture medium. Further descrip-
tion of the mathematical model. Figures S2 and S3. Mathematical modelling results for magnetic 
beads with a size of 300 nm. 
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Figure 1:    Protein A coated magnetic nanoparticles (or Protein A/G hybrid coated 300 nm nanopar-
ticles) where functionalized with EpCAM antibodies (a). Transmission electron micrographs of 300 
nm protein A/G hybrid coated nanoparticles (b). Dynamic light scattering measurements of nanopar-
ticle clusters of different size (c).  
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Figure 2: Cell characterization and interactions between magnetic beads and cells. EpCAM 
expression on EpCAM-positive Caco-2 cells (a) and EpCAM-negative THP-1 cells (b). Flow 
cytometry analysis of PI and Annexin stained Caco-2 cells following exposure to magnetic beads (300 
nm) for 24 hours and comparison to silica nanoparticles (Aerosil200) (n=2) (c). Tumor cell 
separation efficiency using magnetic beads functionalized with EpCAM and beads without antibodies 
and an incubation time of 10 mins (n=2) (d). 
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Figure 3: Study of the magnetic bead – cell interactions. Tumor cell separation efficiency as a func-
tion of bead size (a) in presence of tumor cells only (TC), tumor cells and white blood cells (TC and 
WBC) and tumor cells and fixed white blood cells (TC and fixed white blood cells). Separation effi-
ciency using 300 nm magnetic beads as a function of bead concentration and incubation time (1 min 
and 10 min) (b). The influence of bead-fluid contact time for particle concentrations of 0.2 mg per mL 
is shown for tumor cells in presence of white blood cells (c). The neutrophil count in the supernatant is 
shown as a function of incubation time with 300 nm magnetic beads at a concentration of 0.2 mg per 
mL (n=3) (d). 
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Figure 4: Particle Uptake. Transmission electron micrographs of tumor cells (TC) and white blood 
cells (WBC) (and red blood cells (RBC)) incubated with 300 nm and 4 μm particles for 1 minute or 5 
hours, respectively. The 300 nm particles are localized primarily on the membrane of tumor cells after 
short incubation times (a). Some 300 nm particles can be found inside both TC and WBC. Smaller 
particles are more readily internalized (black arrows). Most of the 4 μm particles are located extracel-
lularly, however, occasionally, also 4 μm particles (MP) can be found inside of cells (b, termed as in-
tracellular microparticles (iMP)).  
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Figure 5: Study of the magnetic bead fluid contact. A device for continuous operation has been as-
sembled. Two different geometries are investigated (a). Geometry A consists of a silicon tube with a 
total volume of 5 mL and a volume of 3 mL between the bead injection point and the magnetic separa-
tor. Geometry B consists out of the same type of silicon tubing but the tubing is connected to a pearl 
chain microfluidic chip mixer (a, b). The volume between the injection point and the separator again 
is 3mL. The tumor cell separation efficiencies are compared for the two geometries (n≥2) (c). 
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Figure 6: Mathematical modelling results for magnetic beads with a size of 300 nm and a number 
concentration of 5 x 109 beads per mL. Change in magnetic nanoparticle concentration as a function 
of cell number (10-105 per mL) concentration and time (a). The fraction of cells with no magnetic par-
ticles attached as a function of cell number concentration and time (b).The average number of mag-
netic particles attached to a cell (c) and the time evolution of the fraction of cells carrying at least 10 
particles (d).  
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